FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10905811000001100: Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Apr 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
37310101000001115 Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
52578001000001119 Epirubicin 200mg/100ml solution for infusion vials (Hospira UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Is a Epirubicin hydrochloride 2mg/mL injection solution 100mL vial false Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has active ingredient Epirubicin hydrochloride true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has active ingredient Anthracycline false Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Is a Epirubicin hydrochloride 2mg/mL infusion solution 100mL vial false Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has specific active ingredient Epirubicin hydrochloride true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Is a Epirubicin 200mg/100ml solution for infusion vials false Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Is a Epirubicin 200mg/100ml solution for infusion vials true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) 1 vial Is pack of False Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier
Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) 1 vial Has AMP True Epirubicin 200mg/100ml solution for injection vials (Mayne Pharma Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start